Drug class
Isavuconazole prodrug; triazole antifungal
Mechanism of action
Isavuconazonium is hydrolysed to isavuconazole, which inhibits fungal lanosterol 14-alpha-demethylase (CYP51), impairing ergosterol biosynthesis and fungal cell-membrane formation.
General use cases
- Treatment of invasive aspergillosis in adults
- Treatment of invasive mucormycosis in adults; use is product-label specific and should be directed by specialist infectious-disease care
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
